Walgreens is now offering RSV vaccines for older adults

Walgreens is now offering RSV vaccines for older adults


Respiratory syncytial virus viral vaccine under research.

Hailshadow | Istock | Getty Images

Walgreens is now offering the respiratory syncytial virus vaccine for older adults nationwide, the pharmacy chain said on Tuesday.

People ages 60 and older can schedule an appointment this week through Walgreens’ app, website, by phone or by visiting their local pharmacy.

related investing news

Earnings playbook: How to trade some of the biggest reports this week, including Apple

CNBC Pro

RSV vaccines are now available in most states and appointments will be added on a rolling basis over the next two weeks as more pharmacies receive the shots, according to Walgreens.

This is the first RSV season in which older adults have the option to get vaccinated against the virus. The Food and Drug Administration approved the first RSV vaccines, made by Pfizer and GSK, last spring. The vaccines are administered as a single dose.

CNBC Health & Science

Read CNBC’s latest health coverage:

RSV starts spreading more widely in the fall. The virus kills 6,000 to 10,000 older adults and hospitalizes 60,000 to 160,000 every year, according to the Centers for Disease Control and Prevention.

The CDC has said eligible adults should talk to their doctor about whether they should receive the shot.

CNBC has asked CVS whether it will also have RSV vaccines available ahead of the fall.

Pfizer started directly shipping its RSV vaccine to customers last month and has sufficient stock to meet demand, a company spokesperson said. CNBC has reached out to GSK for comment.

Pfizer’s shot was 85.7% effective at preventing more severe lower respiratory tract disease during the patient’s first RSV season after vaccination. The shot’s efficacy declined slightly to 78.6% about 18 months after vaccination.

GSK’s shot was 94% effective against severe RSV disease in the patient’s season after vaccination. The shot’s efficacy declined to about 78.8% after two RSV seasons.

— CNBC’S Annika Kim Constantino contributed to this story.



Source

RFK Jr.’s vaccine panel weakens recommendation on hepatitis B shot for babies, scrapping universal guidance
Health

RFK Jr.’s vaccine panel weakens recommendation on hepatitis B shot for babies, scrapping universal guidance

Dr. Vicky Pebsworth, from left, Massachusetts Institute of Technology professor Retsef Levi, Case Western Reserve University Professor Catherine Stein and Dr. Raymond Pollak, listen to presentations during an Advisory Committee on Immunization Practices (ACIP) meeting to discuss childhood vaccine schedule changes at the Centers for Disease Control and Prevention in Atlanta, Georgia, U.S., December 4, […]

Read More
Jim Cramer has faith in Danaher’s turnaround as life sciences comes back to life
Health

Jim Cramer has faith in Danaher’s turnaround as life sciences comes back to life

Life sciences stocks are seeing a resurgence — and that’s good news for Danaher . Connecting the dots to better times ahead for the struggling portfolio name, Jim Cramer thinks the industry turnaround is best illustrated by looking at Agilent Technologies ‘ recovery from a post-Covid rut. Shares are up around 50% from their April […]

Read More
‘Advice was so good,’ says CEO who used ChatGPT to pitch new ideas to AI versions of business icons
Health

‘Advice was so good,’ says CEO who used ChatGPT to pitch new ideas to AI versions of business icons

Joanna Stober, Midi Health CEO and co-founder, has never had an opportunity to run her business plans past legendary venture capital investor John Doerr, chairman at Kleiner Perkins. But that didn’t stop her from tapping Doerr, in an AI version, for advice on growing her startup, a virtual clinic offering midlife health care for women. […]

Read More